Nelson R Newberry, MD in Fremont, CA - Medicare Internal Medicine

Nelson R Newberry, MD is a medicare enrolled "Hospitalist" physician in Fremont, California. He graduated from medical school in 2003 and has 21 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice Permanente Medical Group Inc and his current practice location is 39400 Paseo Padre Pkwy, Fremont, California. You can reach out to his office (for appointments etc.) via phone at (510) 795-3000.

Nelson R Newberry is licensed to practice in California (license number A94031) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1821176405.

Contact Information

	Nelson R Newberry, MD
	39400 Paseo Padre Pkwy, Fremont, CA 94538-2310
	(510) 795-3000
	Not Available

Physician's Profile

Full Name	Nelson R Newberry
Gender	Male
Speciality	Internal Medicine
Experience	21 Years
Location	39400 Paseo Padre Pkwy, Fremont, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Nelson R Newberry graduated from medical school in 2003

NPI Data:

NPI Number: 1821176405
Provider Enumeration Date: 11/01/2006
Last Update Date: 12/09/2021

Medicare PECOS Information:

PECOS PAC ID: 2466556097
Enrollment ID: I20070409000305

Medical Identifiers

Medical identifiers for Nelson R Newberry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821176405	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	A94031 (California)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Kaiser Foundation Hospital - San Leandro	San leandro, CA	Hospital
Kaiser Foundation Hospital - Fremont	Fremont, CA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Permanente Medical Group Inc	8921910225	7800

News Archive

First city-wide study of impact of widespread HIE data access in EDs

Sharing of electronic health information across every major emergency department in the Memphis, Tenn., area resulted in reduced hospital admissions, reduced radiology tests and an annual cost savings of nearly $2 million, according to a Vanderbilt study released today by the Journal of the American Medical Informatics Association.

Aesynt completes acquisition of Health Robotics

Aesynt™, a leading provider of integrated pharmacy automation solutions for hospitals and health systems, announced it has completed the acquisition of Health Robotics, the leading global supplier of automated technology for intravenous (IV) medication preparation, compounding and dispensing.

Debiopharm Group, Biocartis sign investment agreement

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and which has embarked in the field of companion diagnostics with a view to progressing in the area of personalized medicine, today announced the signature of an investment agreement with Biocartis.

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Oncolytics Biotech Inc. announced today that abstracts covering clinical research with reovirus (REOLYSIN(R)) are available on the American Society of Clinical Oncology website at www.asco.org, and on the Oncolytics website at www.oncolyticsbiotech.com.

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Nelson R Newberry allows following entities to bill medicare on his behalf.

Entity Name	Permanente Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710

News Archive

First city-wide study of impact of widespread HIE data access in EDs

Aesynt completes acquisition of Health Robotics

Debiopharm Group, Biocartis sign investment agreement

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nelson R Newberry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nelson R Newberry, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262	Nelson R Newberry, MD 39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 Ph: (510) 795-3000

News Archive

First city-wide study of impact of widespread HIE data access in EDs

Aesynt completes acquisition of Health Robotics

Debiopharm Group, Biocartis sign investment agreement

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Hospitalist Doctors in Fremont, CA

Shambhavi Iyer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000
Karuna Gudur, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000
Niti K. Mann, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000
Tabassum Alam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000
David T. Chiu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000
Savitha Sundararaj, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000
Mayura Suryanarayan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000

Nelson R Newberry, MD - Medicare Internal Medicine in Fremont, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

First city-wide study of impact of widespread HIE data access in EDs

Aesynt completes acquisition of Health Robotics

Debiopharm Group, Biocartis sign investment agreement

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Medicare Reassignments

First city-wide study of impact of widespread HIE data access in EDs

Aesynt completes acquisition of Health Robotics

Debiopharm Group, Biocartis sign investment agreement

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

First city-wide study of impact of widespread HIE data access in EDs

Aesynt completes acquisition of Health Robotics

Debiopharm Group, Biocartis sign investment agreement

Combination of reovirus and carboplatin/paclitaxel shows promising anticancer activity in SCCHN

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Hospitalist Doctors in Fremont, CA